National and Kapodistrian University of Athens
Ηπατικές εκδηλώσεις του συνδρόμου των πολυκυστικών ωοθηκών στην εφηβεία
Abstract
dc:descriptionObjective: To study the prevalence of nonalcoholic fatty liver disease (NAFLD) and circulating hepatokines (organokines produced by the liver cells) in adolescents with polycystic ovary syndrome (PCOS) vs. healthy controls. Materials and methods: Adolescent girls, aged 13-21 years, at least 2 years after menarche, were eligible to enter the study. The diagnosis of PCOS was based on the Rotterdam criteria whereas NAFLD was assessed by liver ultrasound, liver elastography and calculated indices (Fatty liver index - FLI, Liver fat score - LFS, Lipid accumulation product - LAP, ALT/triglycerides, Hepatic steatosis index - HSI, PCOS hepatic steatosis index, Visceral adiposity index – VAI, Fibrosis-4 index – FIB-4, NAFLD fibrosis score - NFS, ΒARD score, AST to Platelet Ratio Index – APRI, and BAAT score). Serum concentrations of fibroblast growth factor (FGF21), selenoprotein P and fetuin A were measured with ELISA (Εnzyme Linked Immunosorbent Assay).Results: A total of 87 adolescents, 47 with PCOS and 40 controls, with mean age 15,31 (± SD 1,55) years participated in the study and underwent clinical, laboratory and imaging evaluation. Adolescents with PCOS vs. controls had a higher prevalence of NAFLD diagnosed both by ultrasound (22,7% vs. 6,1%, p=0,046) and HSI (40.9% vs. 14.2%, p=0,010), and significantly worse LFS, FLI, and ALT/triglycerides scores (p=0,019, p=0,007 and p=0,009 respectively). Nevertheless, there was no significant difference in hepatic fibrosis (assessed by Fibroscan®) between adolescents with PCOS and controls. Adolescents with PCOS and concurrent NAFLD had significantly worse hyperandrogenism, insulin resistance and lipid parameters than adolescents with PCOS and healthy liver [free androgen index (FAI) 5,31(IQR=5,69) vs. 3,05(3,48), p=0,034; HOMA-IR 3,16(2,03) vs. 2,02(0,89), p=0,002; LDL 94,07±29,08 vs. 77,56±20,21, p=0,031; and triglycerides 75,00(31,00) vs. 51,50(30,90), p=0,019]. Regression analysis revealed that 1 pg/mL increase of FGF21, increased by 1% the odds of diagnosing NAFLD by ultrasound, when all other parameters remained unchanged. Selenoprotein P and Sex hormone binding globulin (SHBG) were lower in adolescents with PCOS than controls. Additionally, selenoprotein P was associated with testosterone levels and FAI (r=0,325, p=0,007 and r=0,361, p=0,002) while SHBG was associated with several metabolic parameters. Conclusion: The prevalence of NAFLD was higher in adolescents with PCOS than controls. Hepatokines were associated with metabolic and hyperandrogenism parameters and could be used as biomarkers for fatty liver. The burden of liver steatosis in PCOS, which is evident from adolescence, suggests routine screening of all adolescents with PCOS for NAFLD.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Giannouli, Aikaterini
- Γιαννούλη, Αικατερίνη
Subjects
dc:subject × 19- Σύνδρομο πολυκυστικών ωοθηκών
- Εφηβεία
- Λιπώδες ήπαρ
- Ηπατοκίνες
- Μη αλκοολική λιπώδης νόσος του ήπατος
- Polycystic ovary syndrome (PCOS)
- PCOS
- Adolescence
- Hepatokines
- Nonalcoholic fatty liver disease
- NAFLD
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Μαιευτική και Γυναικολογία
- Παιδιατρική, Νεογνολογία και Υγεία του παιδιού
- Clinical Medicine
- Medical and Health Sciences
- Obstetrics and Gynecology
- Pediatrics, Perinatology and Child Health
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54214